These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 17304469)

  • 41. XDR-TB--danger ahead.
    Singh MM
    Indian J Tuberc; 2007 Jan; 54(1):1-2. PubMed ID: 17455416
    [No Abstract]   [Full Text] [Related]  

  • 42. [Primary drug resistance of Mycobacterium tuberculosis in adolescents with tuberculosis: the specific features of its clinical course, the efficiency of treatment].
    Firsova VA; Poluektova FG; Ryzhova AP
    Probl Tuberk Bolezn Legk; 2008; (5):17-20. PubMed ID: 18711813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?
    Coker R
    Int J Tuberc Lung Dis; 2002 Aug; 6(8):649-50. PubMed ID: 12150473
    [No Abstract]   [Full Text] [Related]  

  • 44. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
    Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
    Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
    [No Abstract]   [Full Text] [Related]  

  • 45. Drug resistant tuberculosis: a global public health issue.
    Sampathkumar P
    Int J Dermatol; 2008 Oct; 47(10):985-8. PubMed ID: 18986340
    [No Abstract]   [Full Text] [Related]  

  • 46. Unsexy tuberculosis.
    Reichman LB
    Lancet; 2009 Jan; 373(9657):28. PubMed ID: 19121719
    [No Abstract]   [Full Text] [Related]  

  • 47. Drug resistant tuberculosis in India--is it a matter of concern?
    Behera D
    Indian J Tuberc; 2007 Jul; 54(3):105-9. PubMed ID: 17886697
    [No Abstract]   [Full Text] [Related]  

  • 48. Extensively drug-resistant tuberculosis. Recent outbreaks highlight the need for improved prevention, control, and surveillance programs.
    Todd B
    Am J Nurs; 2007 Jun; 107(6):29-31. PubMed ID: 17519597
    [No Abstract]   [Full Text] [Related]  

  • 49. A new epidemic.
    Pradhan MC
    J Indian Med Assoc; 1996 Sep; 94(9):326-7, 333. PubMed ID: 9019075
    [No Abstract]   [Full Text] [Related]  

  • 50. Public health. Responding to market failures in tuberculosis control.
    Gupta R; Kim JY; Espinal MA; Caudron JM; Pecoul B; Farmer PE; Raviglione MC
    Science; 2001 Aug; 293(5532):1049-51. PubMed ID: 11463877
    [No Abstract]   [Full Text] [Related]  

  • 51. Investigation of a genotype cluster of tuberculosis cases--Detroit, Michigan, 2004-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Mar; 58(9):226-9. PubMed ID: 19282814
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NIAID describes research priorities for fighting drug-resistant tuberculosis.
    Home Healthc Nurse; 2008 Sep; 26(8):448-9. PubMed ID: 18787482
    [No Abstract]   [Full Text] [Related]  

  • 53. Worrisome news from Mexico: drug resistance and DNA fingerprinting.
    Burman WJ
    Int J Tuberc Lung Dis; 2001 Apr; 5(4):299-300. PubMed ID: 11334245
    [No Abstract]   [Full Text] [Related]  

  • 54. Drug treatment options for multidrug-resistant tuberculosis.
    Patel K
    Conn Med; 1994 Apr; 58(4):227-30. PubMed ID: 8045123
    [No Abstract]   [Full Text] [Related]  

  • 55. Representative drug susceptibility patterns for guiding design of re-treatment regimens for multidrug-resistant tuberculosis in Iran.
    Tabarsi P; Nooraki A; Mirsaeidi M; Amiri M; Baghaei P; Farnia P; Kazempour M; Heidarnazhad H; Alipanah N; Mansouri D; Masjedi MR
    Respirology; 2008 Jan; 13(1):108-11. PubMed ID: 18197919
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extensively drug-resistant (XDR) tuberculosis: an old and new threat.
    Fattorini L; Migliori GB; Cassone A
    Ann Ist Super Sanita; 2007; 43(4):317-9. PubMed ID: 18209265
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surgical aspects of thoracic tuberculosis: a contemporary review--part 2.
    Pezzella AT; Fang W
    Curr Probl Surg; 2008 Nov; 45(11):771-829. PubMed ID: 18809087
    [No Abstract]   [Full Text] [Related]  

  • 58. From threat to reality: the real face of multidrug-resistant tuberculosis.
    Espinal M; Raviglione MC
    Am J Respir Crit Care Med; 2008 Aug; 178(3):216-7. PubMed ID: 18650570
    [No Abstract]   [Full Text] [Related]  

  • 59. Multidrug-resistant tuberculosis in children: two cases and a review of the literature.
    Schluger NW; Lawrence RM; McGuiness G; Park M; Rom WN
    Pediatr Pulmonol; 1996 Feb; 21(2):138-42. PubMed ID: 8882216
    [No Abstract]   [Full Text] [Related]  

  • 60. Primary and acquired drug resistance in childhood tuberculosis.
    Khalilzadeh S; Boloorsaz MR; Safavi A; Farnia P; Velayati AA
    East Mediterr Health J; 2006 Nov; 12(6):909-14. PubMed ID: 17333839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.